KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Exact Sciences (EXAS) Operating Expenses (2016 - 2025)

Exact Sciences (EXAS) has disclosed Operating Expenses for 16 consecutive years, with $698.4 million as the latest value for Q4 2025.

  • On a quarterly basis, Operating Expenses fell 39.82% to $698.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.5 billion, a 17.05% decrease, with the full-year FY2025 number at $2.5 billion, down 17.05% from a year prior.
  • Operating Expenses was $698.4 million for Q4 2025 at Exact Sciences, up from $609.5 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $1.2 billion in Q4 2024 to a low of -$16.4 million in Q4 2023.
  • A 5-year average of $599.5 million and a median of $655.7 million in 2022 define the central range for Operating Expenses.
  • Peak YoY movement for Operating Expenses: tumbled 256.31% in 2023, then soared 7160.25% in 2024.
  • Exact Sciences' Operating Expenses stood at $695.3 million in 2021, then plummeted by 98.49% to $10.5 million in 2022, then crashed by 256.31% to -$16.4 million in 2023, then skyrocketed by 7160.25% to $1.2 billion in 2024, then plummeted by 39.82% to $698.4 million in 2025.
  • Per Business Quant, the three most recent readings for EXAS's Operating Expenses are $698.4 million (Q4 2025), $609.5 million (Q3 2025), and $564.6 million (Q2 2025).